Evidence map›Paper›PMID 41406229›Full record

ArticleScience advances2025

GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis.

Erin C Bogacki, Gustavo Morrone Parfitt, Adriana Cunha, George Longmore, Selina Wray, Patrick A Lewis, Susanne Herbst

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Lysosomes' fallback strategies: more than just survival or death.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erin C BogackiDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Camden, NW1 0TU, UK.ORCID 0000-0001-9594-8272
Gustavo Morrone ParfittDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.ORCID 0000-0003-0168-4099
Adriana CunhaDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.ORCID 0009-0001-1268-410X
George LongmoreDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Camden, NW1 0TU, UK.ORCID 0009-0009-3340-5438
Selina WrayDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Patrick A LewisDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Camden, NW1 0TU, UK.ORCID 0000-0003-4537-0489
Susanne HerbstDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Camden, NW1 0TU, UK.ORCID 0000-0003-2255-7371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies have identified

Indexed as

ExocytosisLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LysosomesMembrane GlycoproteinsAnimalsBiomarkersEye ProteinsHumansMacrophagesMiceParkinson DiseaseBiomarkersEye ProteinsGPNMB protein, humanGpnmb protein, mouseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanMembrane Glycoproteins

Identifiers

PMID41406229
PMCPMC13142706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.